Winnepeg
Winnepeg
Winnepeg, Manitoba, Canada3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, hereditary disease, hypophosphatasia, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease | Active, not recruiting | Phase 3 | 2026-06-22 | NCT06079281 | |
| Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, hereditary disease, hypophosphatasia, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease | Active, not recruiting | Phase 3 | 2026-05-28 | NCT06079359 | |
| Study of JK07 in Patients With Chronic Heart Failure | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial flutter, cardiovascular disorder, diastolic heart failure, fibromatosis, gingival, 2, heart disorder, heart failure, systolic heart failure | Active, not recruiting | Phase 2 | 2026-05-22 | NCT06369298 |